Unknown

Dataset Information

0

Actionable Potentials of Less Frequently Mutated Genes in Colorectal Cancer and Their Roles in Precision Medicine.


ABSTRACT: Global statistics have placed colorectal cancer (CRC) as the third most frequently diagnosed cancer and the fourth principal cause of cancer-related deaths worldwide. Improving survival for CRC is as important as early detection. Personalized medicine is important in maximizing an individual's treatment success and minimizing the risk of adverse reactions. Approaches in achieving personalized therapy in CRC have included analyses of specific genes with its clinical implications. Tumour genotyping via next-generation sequencing has become a standard practice to guide clinicians into predicting tumor behaviour, disease prognosis, and treatment response. Nevertheless, better prognostic markers are necessary to further stratify patients for personalized treatment plans. The discovery of new markers remains indispensable in providing the most effective chemotherapy in order to improve the outcomes of treatment and survival in CRC patients. This review aims to compile and discuss newly discovered, less frequently mutated genes in CRC. We also discuss how these mutations are being used to assist therapeutic decisions and their potential prospective clinical utilities. In addition, we will summarize the importance of profiling the large genomic rearrangements, gene amplification, and large deletions and how these alterations may assist in determining the best treatment option for CRC patients.

SUBMITTER: Mohd Yunos RI 

PROVIDER: S-EPMC7175115 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Actionable Potentials of Less Frequently Mutated Genes in Colorectal Cancer and Their Roles in Precision Medicine.

Mohd Yunos Ryia Illani RI   Ab Mutalib Nurul Syakima NS   Tieng Francis Yew Fu FYF   Abu Nadiah N   Jamal Rahman R  

Biomolecules 20200320 3


Global statistics have placed colorectal cancer (CRC) as the third most frequently diagnosed cancer and the fourth principal cause of cancer-related deaths worldwide. Improving survival for CRC is as important as early detection. Personalized medicine is important in maximizing an individual's treatment success and minimizing the risk of adverse reactions. Approaches in achieving personalized therapy in CRC have included analyses of specific genes with its clinical implications. Tumour genotypin  ...[more]

Similar Datasets

| S-EPMC5036215 | biostudies-literature
| S-EPMC8774614 | biostudies-literature
| S-EPMC4267152 | biostudies-literature
| S-EPMC5664811 | biostudies-literature
| S-EPMC9570321 | biostudies-literature
| S-EPMC4283570 | biostudies-literature
| S-EPMC5706417 | biostudies-literature
| S-EPMC7012442 | biostudies-literature
| S-EPMC8699817 | biostudies-literature
| S-EPMC4609254 | biostudies-literature